These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6086867)

  • 1. Epstein-Barr virus infection and immunologic abnormalities.
    Etzioni A
    J Pediatr; 1984 Aug; 105(2):336. PubMed ID: 6086867
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis.
    Falk K; Ernberg I; Sakthivel R; Davis J; Christensson B; Luka J; Okano M; Grierson HL; Klein G; Purtilo DT
    Int J Cancer; 1990 Dec; 46(6):976-84. PubMed ID: 2174416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL
    Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
    [No Abstract]   [Full Text] [Related]  

  • 4. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome.
    Sakamoto K; Freed HJ; Purtilo DT
    J Immunol; 1980 Aug; 125(2):921-5. PubMed ID: 6248598
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
    Purtilo DT
    Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immune response to Epstein-Barr virus].
    Kanegane H; Miyawaki T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():564-7. PubMed ID: 16615535
    [No Abstract]   [Full Text] [Related]  

  • 8. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epstein-Barr virus. Its participation in lymphoproliferative and anaplastic processes].
    Fejes M; Bachmann AE; Mochanko K
    Medicina (B Aires); 1978; 38(6 Pt 1):700-16. PubMed ID: 220495
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lymphoproliferative disorders: Epstein-Barr virus and heritable predisposition].
    Ohga S
    Rinsho Ketsueki; 2014 Oct; 55(10):2221-4. PubMed ID: 25297790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epstein-Barr virus infection: immunology and immunopathology].
    Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases.
    Schuster V; Herold M; Wachter H; Reibnegger G
    Infection; 1993; 21(4):210-3. PubMed ID: 8225623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
    Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD
    J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.
    Weiss LM; Movahed LA
    Am J Pathol; 1989 Mar; 134(3):651-9. PubMed ID: 2538060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and its antigens.
    Raab-Traub N; Pagano JS
    Immunol Ser; 1989; 43():477-98. PubMed ID: 2562309
    [No Abstract]   [Full Text] [Related]  

  • 18. The spectrum of Epstein-Barr virus disease.
    O'Dell JR
    Nebr Med J; 1981 Dec; 66(12):275-8. PubMed ID: 6283398
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous lymphoproliferative disorder complicating infectious mononucleosis in an immunosuppressed patient.
    Owen CE; Callen JP; Bahrami S
    Pediatr Dermatol; 2011; 28(2):149-55. PubMed ID: 20497356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.
    Sullivan JL; Byron KS; Brewster FE; Purtilo DT
    Science; 1980 Oct; 210(4469):543-5. PubMed ID: 6158759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.